Omni Shoreham Hotel

NIDA Director to Deliver Keynote; Innovative Toxicology Research to Feature at 2024 ACMT Annual Scientific Meeting and Symposia in Washington, DC

Retrieved on: 
Wednesday, January 17, 2024
AACT, PFAS, Drug Safety, Occupational medicine, Addiction medicine, Research, ASM, Senior counsel, Health, Opioid, Antidote, Challenge, American Academy, Society, IST, Naloxone, Society of Toxicology, Public, Red, Omni Shoreham Hotel, Equity, Nursing, ASAM, Adolescence, American College, Physician

This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.

Key Points: 
  • This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.
  • Please note that registration for individual symposia is separate from the three-day main meeting.
  • The 2024 ACMT Annual Scientific Meeting main program will initiate on Friday, April 12.
  • Register now for the 2024 ACMT Annual Scientific Meeting and Symposia.

AAMI and FDA Co-Sponsor Medtech Conference, ‘AAMI and FDA neXus'

Retrieved on: 
Monday, January 8, 2024
Nexus, Conference, University of Utah, Food, Johnson & Johnson, FDA, NEXUS, ISC, QSR, AAMI, ASCA, University, Omni Shoreham Hotel, Sterilization, Device, CDRH, Ethylene oxide, ISO, USB On-The-Go, Intuitive Surgical, Medical device

The conference will feature a wealth of FDA experts alongside industry members and will focus on the latest information on medical device regulations and standards.

Key Points: 
  • The conference will feature a wealth of FDA experts alongside industry members and will focus on the latest information on medical device regulations and standards.
  • Real-world evidence and medical device safety, presented by Daniel Caños, director of the Office of Clinical Evidence and Analysis at CDRH.
  • The FDA case for quality, delivered by Francisco Vicenty, FDA consumer safety officer.
  • Development, adoption, and now application of standards, neXus covers it all.”
    Those interested in attending can find registration for the AAMI FDA neXus here .

CG Oncology Announces Presentation of the First Phase 3 Monotherapy Data for Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC Patients at SUO 2023

Retrieved on: 
Tuesday, November 14, 2023
Research, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Oncology, BCG, Mayo Clinic, Patient, Society, Omni Shoreham Hotel, SUO, NMIBC

BOND-003 ( NCT04452591 ) is a single-arm, open-label, Phase 3 clinical trial evaluating cretostimogene grenadenorepvec as monotherapy in patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

Key Points: 
  • BOND-003 ( NCT04452591 ) is a single-arm, open-label, Phase 3 clinical trial evaluating cretostimogene grenadenorepvec as monotherapy in patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
  • The study enrolled 116 patients with BCG-unresponsive NMIBC across North America and the Asia-Pacific region.
  • The primary endpoint of the study is complete response (CR) at any time, with duration of response measured as a secondary endpoint.
  • Details of the oral presentation are as follows:
    Presenter: Mark D. Tyson, M.D., Urologic Oncologist at Mayo Clinic, Scottsdale, AZ

Meet the Winners of the 2023 Diversity Impact Awards

Retrieved on: 
Tuesday, October 17, 2023
Professional Services, Human Resources, DEI (Diversity, Equity and Inclusion), Omni, Multimedia, Omni Shoreham Hotel, Executive sponsor, Organization, Culture, DC, Bacup, Impact, Entrepreneurship, Employee resource group, Dimension, Erg, Learning, Conference, Management

Talent Dimensions and the Global ERG Network recognized the outstanding achievements of Employee Resource Groups, Business Resource Groups and Diversity Councils at the 2023 Diversity Impact Awards ceremony at the Global ERG Network Conference at the Omni Shoreham in Washington, DC October 11 – 13, 2023.

Key Points: 
  • Talent Dimensions and the Global ERG Network recognized the outstanding achievements of Employee Resource Groups, Business Resource Groups and Diversity Councils at the 2023 Diversity Impact Awards ceremony at the Global ERG Network Conference at the Omni Shoreham in Washington, DC October 11 – 13, 2023.
  • “The recipients of The Diversity Impact Awards displayed excellence in driving results in organizational impact, talent management and supporting a culture of inclusion, along with other criteria,” said Cowart.
  • The 2023 Diversity Impact Awards continue to build on its previous success as the leader in diversity impact and performance measurement.
  • You can view the 2023 Diversity Impact Awards recipients here .

Introducing AAMI neXus, the Evolved International Standards Conference

Retrieved on: 
Monday, October 16, 2023
Omni, European, USB On-The-Go, Omni Shoreham Hotel, AAMI, FDA Center for Devices and Radiological Health, AI, CDRH, FDA, ISO, Medical device, Association for the Advancement of Medical Instrumentation, NEXUS, Device, Health equity, IEC, ISC, Cloud computing, Conference, Risk management

Held from February 20 to 23, 2024, at the Omni Shoreham Hotel in Washington, D.C., AAMI neXus takes the place of the International Standards Conference (ISC).

Key Points: 
  • Held from February 20 to 23, 2024, at the Omni Shoreham Hotel in Washington, D.C., AAMI neXus takes the place of the International Standards Conference (ISC).
  • Since 1991, ISC was the must attend conference for industry and regulatory leaders involved in the development and adoption of medical device standards.
  • AAMI neXus features ISC’s previous programming but includes a new focus on applying medical device standards.
  • Robert Burroughs, AAMI chief learning and development officer said, “We’re excited to bring the same focus from ISC to AAMI neXus but to add material on standards application.

AlphaGraphics recognizes high-achieving franchisees at 53rd conference

Retrieved on: 
Thursday, August 24, 2023
Omni, Printing, AlphaGraphics, Omni Shoreham Hotel, McPherson, Family, Marketing, Video game

DENVER, Aug. 24, 2023 /PRNewswire/ -- AlphaGraphics, a leading franchisor of printing and marketing solutions, recently recognized its high-achieving franchisees while also discussing strategies for the future during its 53rd annual conference at Omni Shoreham Hotel in Washington, D.C.

Key Points: 
  • DENVER, Aug. 24, 2023 /PRNewswire/ -- AlphaGraphics , a leading franchisor of printing and marketing solutions, recently recognized its high-achieving franchisees while also discussing strategies for the future during its 53rd annual conference at Omni Shoreham Hotel in Washington, D.C.
    "At AlphaGraphics, our franchise owners and leadership team have a win-win relationship," said Bill McPherson, vice president of franchise development.
  • Our annual conference gives us an opportunity to come together as a franchise family and work on strategies that help us all grow."
  • Several awards were given out at this year's conference, including:
    "Our franchisees deserve all the recognition for their hard work and dedication to making AlphaGraphics successful," McPherson said.
  • AlphaGraphics was founded in 1970, and the company began offering franchise opportunities in 1979.

CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition

Retrieved on: 
Wednesday, February 22, 2023
Omni, Motion, Physician, Clinical Science (journal), Omni Shoreham Hotel, Innovation, Patient, Heart, Skin, Heart failure, Research, CRT, Congress, Death, Survival, Partnership, Nursing, Doctor of Philosophy, MD, Medical device

LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington DC, February 25 - 28, 2023.

Key Points: 
  • LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington DC, February 25 - 28, 2023.
  • The Syntach technology also qualifies for the CRT 2023 Top Innovation Award.
  • during the Innovations HUB:
    CRT's Best Innovation Competition session on Monday, February 27th, 2023, at 4:11 PM CET
    Syntach and Meditrial recently announced a partnership to support the development of clinical and regulatory strategies for Syntach's innovative minimally invasive cardiac support system.
  • "We are excited that Syntach CS will be featured in this year's Best Innovation Competition," said Patrick NJ Schnegelsberg, CEO of Syntach. "

CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition

Retrieved on: 
Wednesday, February 22, 2023
Omni, Motion, Physician, Clinical Science (journal), Omni Shoreham Hotel, Innovation, Patient, Heart, Skin, Heart failure, Research, CRT, Congress, Death, Survival, Partnership, Nursing, Multimedia, Doctor of Philosophy, MD, Medical device

LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington DC, February 25 - 28, 2023.

Key Points: 
  • LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the Omni Shoreham Hotel in Washington DC, February 25 - 28, 2023.
  • The Syntach technology also qualifies for the CRT 2023 Top Innovation Award.
  • during the Innovations HUB:
    CRT's Best Innovation Competition session on Monday, February 27th, 2023, at 4:11 PM CET
    Syntach and Meditrial recently announced a partnership to support the development of clinical and regulatory strategies for Syntach's innovative minimally invasive cardiac support system.
  • "We are excited that Syntach CS will be featured in this year's Best Innovation Competition," said Patrick NJ Schnegelsberg, CEO of Syntach. "

Patients as Partners® in Clinical Research Announces Keynote Lineup and Key Topics for the 10th Annual Meeting

Retrieved on: 
Wednesday, December 14, 2022
Omni, Partner, Therapy, FNIH, Device, FDA Center for Devices and Radiological Health, Human, R, Conference, Doctor of Philosophy, In the Heights, Patient, Science, CDRH, Takeda Pharmaceutical Company, Takeda, Breast cancer, Omni Shoreham Hotel, FDA, The Heights, SVP, MPH, Center for Drug Evaluation and Research, CDER, OCPP, DC, OCE, Fearless, Pharmaceutical industry, Medical device, MD, Research, Astellas Pharma

NEW YORK, Dec. 14, 2022 /PRNewswire-PRWeb/ -- The Conference Forum announced the launch of the 10th annual Patients as Partners® in Clinical Research Summit with the 2023 keynote lineup and key topics. The program now spans over three days, March 20-22, 2023, at the Omni Shoreham Hotel in Washington, DC.

Key Points: 
  • The Conference Forum announced the launch of the 10th annual Patients as Partners in Clinical Research Summit taking place March 20-22, 2023 in Washington DC with the 2023 keynotes and key topics.
  • NEW YORK, Dec. 14, 2022 /PRNewswire-PRWeb/ -- The Conference Forum announced the launch of the 10th annual Patients as Partners in Clinical Research Summit with the 2023 keynote lineup and key topics.
  • The program now spans over three days, March 20-22, 2023, at the Omni Shoreham Hotel in Washington, DC.
  • "We are thrilled to be presenting the 10th annual Patients as Partners conference, challenging and welcoming the pharma industry to engage patients and their input on developing therapeutics, enabling greater access to clinical trials, and increasing diversity and inclusion," said Kate Woda, Senior Director.

Adam Sachs Honored with the Inaugural NAIFA President's Citation

Retrieved on: 
Friday, November 18, 2022
Omni, Conference, Omni Shoreham Hotel, LACP, CLTC, CFP, Citation, Special adviser (UK), United States congressional conference committee, Mind and Life Institute, Education, Holzberg, National Association, Publication, Chfc, Finance, CLU, Samuel Bryan, Management, Financial adviser, Public relations, Ethics, Sachs

FALLS CHURCH, Va., Nov. 18, 2022 /PRNewswire-PRWeb/ -- Lawrence Holzberg, LACP, LUTCF, President of the National Association of Insurance and Financial Advisors (NAIFA) is pleased to announce that Adam Sachs, CFP®, CLU®, ChFC®, CLTC, AIF®, a Financial Advisor with Centinel Financial Group, LLC, in Needham, MA, is the recipient of the inaugural 2023 NAIFA President's Citation.

Key Points: 
  • Holzberg presented the citation to Sachs on November 14 at NAIFA's Belong awards celebration at the Omni Shoreham in Washington, D.C. in front of over 300 NAIFA members.
  • Sachs has been a loyal NAIFA member since 1994 and is a Past President of NAIFA's Massachusetts chapter (NAIFA-MA).
  • Sachs was the 2021 NAIFA-MA Membership Chair and is currently a Vice Chair of NAIFA's National Membership Committee.
  • "Adam Sachs has done great work on behalf of NAIFA as an innovative and tireless recruiter of new members and also as a leader in NAIFA's grassroots advocacy efforts.